Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

21 January 2023: Database Analysis

NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma

Zigang Li 1ABCDEF* , Chengshan You 2ADF , Jun Huang 1CD , Ming Zhang 1BE

DOI: 10.12659/MSM.938410

Med Sci Monit 2023; 29:e938410

Figure 1 HCC patients with elevated NFYA expression had significantly worse survival(A–F) K-M analysis for DSS (B, D, F) and PFS (A, C, E) comparison was performed. Patients with primary HCC in TCGA were classified into 2 groups by the median NFYA (A, B), NFYB (C, D) or NFYC (E, F) expression. (G) NFYA protein expression in normal liver and HCC tissues. IHC staining images were obtained from the HPA, from the following links: https://www.proteinatlas.org/ENSG00000001167-NFYA/tissue/liver and https://www.proteinatlas.org/ENSG00000001167-NFYA/pathology/liver+cancer#ihc.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750